Investor · Warsaw, R9

George Swirski

Open George in the network graph →

Filings

8

SEC Form D

Connections

60

co-filers

Capital

$351.0M

across filings

Active

Dec 2015

to May 2020

Most-connected co-filers (60)

Stephen Richmond · Warsaw, R98 shared Neil Milne · Warsaw, R95 shared Aaron Katz · New York, NY4 shared John Ackerly · Grand Cayman, Cayman Islands4 shared Pawel Gierynski · Warsaw, R94 shared David Icikson · New York, NY3 shared Rachael Classi · CHARLOTTE, NC2 shared Lisa Ganderson · CHARLOTTE, NC2 shared Chatrasingh K. Joyram · Quatre Bornes, O42 shared Andrew G. Dodson · SAN FRANCISCO, CA2 shared David P. Madden · Cambridge, MA2 shared Charles V. Long · Oklahoma City, OK2 shared Vinzenz P. Ploerer · Cambridge, MA2 shared Jeffrey D. Janus · Medford, MA2 shared Capital Management, Inc. Conrad · Islandia, NY2 shared Steve Barha · VANCOUVER, British Columbia, Canada2 shared Donald E. Conrad · Islandia, NY2 shared Howard Shams · New York, NY2 shared Vincent R. Zurawski · Medford, MA2 shared Marian Nakada · Cambridge, MA2 shared Jonathan Neiss · NEW YORK, NY2 shared Rick P. Lundberg · Cambridge, MA2 shared Jonathan L. Whittle · Grand Cayman, Cayman Islands2 shared John K. Mcgeehan · Medford, MA2 shared

Recent filings (8)

Navitor Pharmaceuticals, Inc.May 2020 · 27 co-filers$20.2M Abris CEE Mid-Market Fund III LPMay 2017 · 15 co-filers$382.0M Abris CEE Mid-Market Fund III LPMay 2017 · 15 co-filers$382.0M Parabellum Partners I, LPNov 2016 · 12 co-filers Parabellum Partners I, LPMay 2016 · 12 co-filers Abris CEE Mid-Market Fund III LPMay 2016 · 15 co-filers$324.2M Abris CEE Mid-Market Fund III LPMay 2016 · 15 co-filers$324.2M Ascendance Biotechnology, Inc.May 2016 · 18 co-filers$300K Ascendance Biotechnology, Inc.Dec 2015 · 8 co-filers$750K Navitor Pharmaceuticals, Inc.Dec 2015 · 25 co-filers$33.3M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See George in the interactive graph →